{"topic_id":"fda-gras_recent_001","category":"us-2026","context":"---\ntopic_id: fda-gras_recent_001\ncategory: FDA-GRAS\ntitle: FDA GRAS Recent Notices\nlang: en\nsource: fda_gras_recent_20260714.html\ndate_parsed: 2026-07-18\ntokens_estimated: 2933\nextra: {\"entry_count\": 727, \"source_tag\": \"recent_html\"}\nsource_document: \"FDA GRAS Notice Inventory\"\ncitation:\n  authority: \"US FDA / USDA APHIS\"\n  title: \"FDA GRAS Recent Notices\"\n  url: \"\"\n  retrieved: \"2026-07-18\"\n  ref: \"\"\n  doc_type: \"official web page\"\n  needs_review: true\nauthority_tier: T1\nauthority_tier_basis: \"T1:fda\"\nauthority_tier_date: 2026-08-04\n---\n\n# FDA GRAS Recent Notices\n\n**Source:** fda_gras_recent_20260714.html\n**Total entries:** 727\n**Date parsed:** 2026-07-18\n\n## Table preview (first 30)\n\n| 1307 | Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |   | FDA has no questions (PDF 236 kB) |\n| --- | --- | --- | --- | --- |\n| 1307 | Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |   | FDA has no questions (PDF 236 kB) |\n| 1303 | Bifidobacterium animalis subsp. lactis CGMCC5470 |   | FDA has no questions (PDF 240 kB) |\n| 1300 | Zeaxanthin produced via fermentation using production strain Yarrowia lipolytica CGMCC 39021 |   | FDA has no questions (PDF 194 kB) |\n| 1299 | 3′-sialyllactose sodium salt produced via fermentation using production strain Escherichia coli “SLIS109” |   | FDA has no questions (PDF 299 kB) |\n| 1296 | Erythritol produced through fermentation of glucose by Yarrowia lipolytica |   | FDA has no questions (PDF 202 kB) |\n| 1294 | Rebaudioside M produced by enzymatic treatment of steviol glycosids purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |   | FDA has no questions (PDF 191 kB) |\n| 1293 | Brazzein preparation produced by Komagataella phaffii RA-b expressing a gene encoding for brazzein from Pentadiplandra brazzeana |   | FDA has no questions (PDF 199 kB) |\n| 1292 | Citrus-derived compounded sweetener made with neohesperidin dihydrochalcone and gamma cyclodextrin |   | FDA has no questions (PDF 631 kB) |\n| 1290 | Glucose oxidase enzyme preparation produced by Komagataella phaffii expressing a gene encoding glucose oxidase from Aspergillus niger |   | FDA has no questions (PDF 201 kB) |\n| 1288 | Enzyme-modified steviol glycosides |   | FDA has no questions (PDF 220 kB) |\n| 1287 | Sucrose oligoesters |   | FDA has no questions  (PDF 234 kB) |\n| 1285 | Saccharomyces cerevisiae BY-927 expressing a gene encoding α-acetolacate decarboxylase enzyme from Acetobacter aceti |   | FDA has no questions  (PDF 255 kB) |\n| 1284 | Recombinant bovine lactoferrin isolate produced by Komagataella phaffii “Ppas_337” expressing the gene encoding bovine lactoferrin |   | FDA has no questions (PDF 201 kB) |\n| 1283 | Bacillus coagulans BC99 spore preparation |   | FDA has no questions (PDF 256 kB) |\n| 1282 | Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni)  |   | FDA has no questions (PDF 257 kB) |\n| 1281 | 2'-Fucosyllactose |   | Notice does not provide a basis for a GRAS determination  (PDF 198 kB) |\n| 1279 | Saccharomyces cerevisiae CCTCC M2025194 |   | FDA has no questions  (PDF 189 kB) |\n| 1278 | Lactiplantibacillus plantarum CGMCC 6312 |   | FDA has no questions  (PDF 291 kB) |\n| 1277 |  Autoclaved Parabacteroides goldsteinii \"RV-01\" |   | FDA ceased to evaluate (PDF 293 kB) |\n| 1276 | Cellulase enzyme preparation produced by Trichoderma reesei expressing a gene encoding a cellulase from Aspergillus niger |   | FDA has no questions  (PDF 260 kB) |\n| 1275 | 6'-Sialyllactose sodium salt |   | FDA has no questions  (PDF 277 kB) |\n| 1274 | 2'-Fucosyllactose |   | FDA has no questions (PDF 353 kB) |\n| 1273 | Lacto- N- tetraose |   | FDA has no questions (PDF 295 kB) |\n| 1272 | Lacto- N-neo tetraose |   | FDA has no questions (PDF 293 kB) |\n| 1271 | Short-chain fructooligosaccharides |   | FDA has no questions  (PDF 234 kB) |\n| 1270 | L-ergothioneine produced by Escherichia coli K-12 MG1655 expressing enzymes from Neurospora crassa and Mycolicibacterium smegmatis MC2 155 |   | FDA has no questions (PDF 230 kB) |\n| 1269 | Modified-monellin preparation produced by Komagataella phaffii CBS 150005 expressing a gene encoding for a modified monellin |   | FDA has no questions (PDF 256 kB) Additional correspondence (PDF 266 kB) |\n| 1268 | Mycelial biomass from Rhizomucor pusillus |   | FDA ceased to evaluate (PDF 158 kB) |\n| 1267 | Sunflower lecithin |   | FDA has no questions (PDF 204 kB) |\n| 1266 | Wheat fiber extract from wheat ( Triticumaestivum ) |   | FDA has no questions (PDF 266 kB) |\n\n... and 697 more entries\n\n","sources":["US FDA / USDA APHIS — FDA GRAS Recent Notices (retrieved 2026-07-18)"],"source":{"authority":"US FDA / USDA APHIS","title":"FDA GRAS Recent Notices","url":"https://www.fda.gov/animal-veterinary/","retrieved":"2026-07-18","ref":"","doc_type":"official web page","source_document":"FDA GRAS Notice Inventory","verification_file":"fda_gras_recent_20260714.html"},"source_document":"FDA GRAS Notice Inventory","source_file":"fda_gras_recent_20260714.html","trust":{"authority_tier":"T1","fidelity":"verbatim","license":null,"display_grade":"A"},"tokens_estimated":2933,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}